< 1 minute read
Dec. 16, 2021
Giredestrant: Oral Selective Estrogen Receptor Degrader (SERD) and Full Antagonist
giredestrant
selective ER degrader (SERD) + full antagonist oral (30 mg QD), Ph. III for ER+, HER2- BC from profiling >4k cmpds for desired MoA Journal of Medicinal Chemistry Genentech, San Francisco, US
Loading...
